scholarly journals Autoantibody Biomarkers for Basal Ganglia Encephalitis in Sydenham Chorea and Pediatric Autoimmune Neuropsychiatric Disorder Associated With Streptococcal Infections

2020 ◽  
Vol 11 ◽  
Author(s):  
Jennifer L. Chain ◽  
Kathy Alvarez ◽  
Adita Mascaro-Blanco ◽  
Sean Reim ◽  
Rebecca Bentley ◽  
...  
2015 ◽  
Vol 5 (4) ◽  
pp. 184-188 ◽  
Author(s):  
Sandy Mullen

Abstract During the past decade, pediatric autoimmune neuropsychiatric disorder associated with streptococcal infections (PANDAS) has become the topic of numerous debates, sparking research on its presentation, existence, and treatment. As the awareness of PANDAS has increased among the general community, health care providers have been forced to increase their knowledge of this controversial disease state. This article will review the background information, diagnostic criteria, treatment, and contentious issues related to PANDAS.


Author(s):  
Susan E. Swedo ◽  
Kyle A. Williams

This chapter reviews evidence for an autoimmune etiology in a subset of pediatric OCD cases. The sudden onset of OCD and related symptoms following an infectious illness in youth has been termed Pediatric Autoimmune Neuropsychiatric Disorder Associated with Streptococcus, or PANDAS. By analogy with the better-understood syndrome of Sydenham Chorea, it has been hypothesized (as the name implies) that this syndrome derives from the development of brain-reactive autoantibodies after infection. The specifics of this pathophysiology have been difficult to establish, and the syndrome remains somewhat controversial. Nevertheless, treatment with antibiotics and immune-modulating therapies has shown promise in these cases.


2016 ◽  
Vol 32 (3) ◽  
pp. 316-321 ◽  
Author(s):  
Sara Maria delle Acque Giorgio ◽  
Maria Grazia Caprio ◽  
Flavia Galante ◽  
Giustina Russo ◽  
Alfonso Romano ◽  
...  

We evaluated whether perfusion brain abnormalities by single-photon emission computed tomography (SPECT) imaging improves diagnostic and prognostic assessment in Sydenham chorea. Twenty-three children with acute autoimmune chorea underwent technetium-99m hexamethylpropyleneamine oxime brain SPECT imaging. In 16 children, SPECT was repeated during the follow-up. A pattern of basal ganglia hyperperfusion was observed in 20 (87%) patients. In 4 of 10 patients with generalized chorea, perfusion was comparable in right and left striatum and right and left thalamus. In 13 patients with hemi-chorea and in 3 with generalized chorea, unilateral hyperperfusion was detected. Three patients with generalized chorea had normal perfusion. Tracer uptake of basal ganglia of the patients at the acute phase was higher than at the follow-up ( P < .001). SPECT seems a useful noninvasive tool in pediatric patients with Sydenham chorea to support the clinicians during the acute phase of disease and to monitor the course of autoimmune chorea.


2017 ◽  
Vol 27 (5) ◽  
pp. 637-643 ◽  
Author(s):  
Jill Leon ◽  
Rebecca Hommer ◽  
Paul Grant ◽  
Cristan Farmer ◽  
Precilla D’Souza ◽  
...  

2020 ◽  
Vol 36 (1) ◽  
pp. 48-53
Author(s):  
Zeynep Selen Karalok ◽  
Zeynep Öztürk ◽  
Altan Gunes ◽  
Esra Gurkas

Background: Our aim in this study was to evaluate the efficacy of magnetic resonance imaging (MRI) studies in the detection of brain regions effected by Sydenham chorea and to determine whether they provided data regarding the pathogenesis of Sydenham chorea. To this end, we assessed basal ganglia structures in Sydenham chorea patients and control group by quantitative MRI volumetric analysis. Methods: Patients with a recent onset of chorea and control subjects matched for age and gender were included in the study. Medical history, laboratory tests, and physical and neurologic examinations were reviewed. All MRIs were considered within normal limits. High-resolution T1-weighted 3D magnetization-prepared rapid acquisition of gradient echo scans were used for quantitative volumetric assessment of the brain via the “volBrain” method. Results: Twenty-four subjects with Sydenham chorea (16 girls and 8 boys, aged between 7 and 16 years) and 35 control subjects were evaluated. Mean age was 11.25 ± 2.89 years for Sydenham chorea patients and 10.58 ± 2.53 years for the controls. No significant difference was found relative to globus pallidus, caudate, and thalamic volumes between patients with Sydenham chorea and controls. The relative mean total, left, and right putamen volumes were significantly larger in patients with Sydenham chorea compared to controls ( P = .003, P = .018, P = .001, respectively). Conclusion: Selective neuroanatomic differences in putamen among other basal ganglia structures and significant increases in size are consistent with a hypothesis of a cross-reactive antibody-mediated inflammation of the putamen as being the pathophysiologic mechanism for this disorder.


2012 ◽  
Vol 27 (11) ◽  
pp. 1470-1481 ◽  
Author(s):  
Russell C. Dale ◽  
Fabienne Brilot

The basal ganglia are deep nuclei in the brain that include the caudate, putamen, globus pallidus, and substantia nigra. Pathological processes involving the basal ganglia often result in disorders of movement and behavior. A number of different autoimmune disorders predominantly involve the basal ganglia and can result in movement and psychiatric disorders. The classic basal ganglia autoimmune disorder is Sydenham chorea, a poststreptococcal neuropsychiatric disorder. Resurgence in the interest in Sydenham chorea is the result of the descriptions of other poststreptococcal neuropsychiatric disorders including tics and obsessive-compulsive disorder, broadly termed pediatric autoimmune neuropsychiatric disorders associated with streptococcal infection. Encephalitic processes affecting the basal ganglia are also described including the syndromes basal ganglia encephalitis, encephalitis lethargica, and bilateral striatal necrosis. Last, systemic autoimmune disorders such as systemic lupus erythematosus and antiphospholipid syndrome can result in chorea or parkinsonism. Using paradigms learned from other autoantibody associated disorders, the authors discuss the autoantibody hypothesis and the role of systemic inflammation in autoimmune basal ganglia disorders. Identification of these entities is important as the clinician has an increasing therapeutic repertoire to modulate or suppress the aberrant immune system.


Sign in / Sign up

Export Citation Format

Share Document